LIPIDEMIA

Clinical trials for LIPIDEMIA explained in plain language.

Never miss a new study

Get alerted when new LIPIDEMIA trials appear

Sign up with your email to follow new studies for LIPIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New pill combo aims to slash cholesterol in High-Risk patients

Disease control Recruiting now

This Phase 3 study tests whether a daily pill combining obicetrapib and ezetimibe, or obicetrapib alone, can lower LDL (bad) cholesterol more than placebo in 300 people with type 2 diabetes or metabolic syndrome. Participants continue their standard cholesterol medications. The m…

Matched conditions: LIPIDEMIA

Phase: PHASE3 • Sponsor: NewAmsterdam Pharma • Aim: Disease control

Last updated Jun 27, 2026 11:00 UTC

LIPIDEMIA

Get alerted when new LIPIDEMIA trials appear

New pill combo aims to slash cholesterol in High-Risk patients